Financials
- Market Capitalization 461.199 M
- Employee 71
- Founded 2020
- CEO N/A
- Website www.bhtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00ZHSKKM1
- Industry N/A
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2942 | BRTM B&R Technology Merger Corp. Class A Ordinary Shares | 9.80 USD | +0.20% | +0.20% | +0.10% | -2.00% | 477.65 M USD | ||
| 2968 | CSHR CoinShares PLC Ordinary Shares | 3.51 USD | -0.85% | +1.15% | -12.25% | -60.91% | 462.55 M USD | ||
| 2976 | GCGR General Catalyst Global Resilience Merger Corp. Class A Ordinary Shares | 9.9600 USD | -0.05% | 0.00% | -0.30% | +9790.76% | 460.02 M USD | ||
| 2977 | BCCQ Bleichroeder Acquisition Corp. III Class A Ordinary Shares | 9.9900 USD | 0.00% | +0.10% | +0.30% | +0.60% | 459.54 M USD |
Frequently asked questions about BlossomHill Therapeutics, Inc. Common Stock
What is the BlossomHill Therapeutics, Inc. Common Stock stock price today?
The current price of BlossomHill Therapeutics, Inc. Common Stock (BLSM) is 14.5100. Over the past 24 hours, the stock has changed by +0.69%. Follow the BLSM chart for real-time price dynamics.
What is the stock ticker of BlossomHill Therapeutics, Inc. Common Stock?
BlossomHill Therapeutics, Inc. Common Stock trades under the ticker BLSM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BlossomHill Therapeutics, Inc. Common Stock stock going up?
BLSM has changed by +3.64% over the last week, -6.21% over the last month, and -7.87% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of BlossomHill Therapeutics, Inc. Common Stock?
BlossomHill Therapeutics, Inc. Common Stock currently has a market capitalization of 461.2 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were BlossomHill Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, BlossomHill Therapeutics, Inc. Common Stock reported earnings of -1.29 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was BlossomHill Therapeutics, Inc. Common Stock revenue for the last quarter?
BlossomHill Therapeutics, Inc. Common Stock reported quarterly revenue of 1.47 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was BlossomHill Therapeutics, Inc. Common Stock net income for the last quarter?
BlossomHill Therapeutics, Inc. Common Stock reported net income of -24.01 M for the last quarter. The previous quarter showed -23.76 M, which means net income changed by -1.07%.
How many employees does BlossomHill Therapeutics, Inc. Common Stock have?
As of the latest available data, BlossomHill Therapeutics, Inc. Common Stock has 71 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy BlossomHill Therapeutics, Inc. Common Stock stock?
You can buy BlossomHill Therapeutics, Inc. Common Stock (BLSM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BlossomHill Therapeutics, Inc. Common Stock stock?
Investing in BlossomHill Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BLSM chart and related analysis on metatrader.com as part of your research.